NEW YORK (GenomeWeb) – Many omics tools and molecular diagnostics firms saw their stock prices decline in April along with a general downturn for biotech stocks. 

The GenomeWeb Index, which tracks 31 firms operating in the omics and MDx space, declined more than 3 percent month over month. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.